Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Sabirsh

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Pharmacology|September 15, 2004
Exploring the pharmacology of the leukotriene B4 receptor BLT1, without the confounding effects of BLT2Alan Sabirsh, Jesper Bristulf, Christer Owman
Nanoscale|February 1, 2022
Physiology, pathology and the biomolecular corona: the confounding factors in nanomedicine designKai Liu, Anna Salvati, Alan Sabirsh
IEEE Journal of Biomedical and Health Informatics|May 24, 2022
SimSearch: A Human-in-The-Loop Learning Framework for Fast Detection of Regions of Interest in Microscopy ImagesAnkit Gupta, Alan Sabirsh, Carolina Wahlby, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 21, 2005
Non-specific effects of leukotriene synthesis inhibitors on HeLa cell physiologyAlan Sabirsh, Jesper Bristulf, Ulf Karlsson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 21, 2007
Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils: novel lipid-peptide interactions in innate immune responsesMin Wan, Alan Sabirsh, Anders Wetterholm, et al.
Biochemistry|May 4, 2006
Residues from transmembrane helices 3 and 5 participate in leukotriene B4 binding to BLT1Alan Sabirsh, Robert P Bywater, Jesper Bristulf, et al.
Journal of Lipid Research|February 24, 2006
15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cellsOliver Schröder, Yulyana Yudina, Alan Sabirsh, et al.
Journal of Lipid Research|April 5, 2005
Fluorescent leukotriene B4: potential applicationsAlan Sabirsh, Anders Wetterholm, Jesper Bristulf, et al.
Nature Communications|May 9, 2024
Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applicationsKai Liu, Elisa Lázaro-Ibáñez, Michael Lerche, et al.
Chemistryopen|April 8, 2021
A Novel Graphene Quantum Dot-Based mRNA Delivery PlatformYa Liu, Changhong Zhao, Alan Sabirsh, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Pharmacology|September 15, 2004
Exploring the pharmacology of the leukotriene B4 receptor BLT1, without the confounding effects of BLT2Alan Sabirsh, Jesper Bristulf, Christer Owman
Nanoscale|February 1, 2022
Physiology, pathology and the biomolecular corona: the confounding factors in nanomedicine designKai Liu, Anna Salvati, Alan Sabirsh
IEEE Journal of Biomedical and Health Informatics|May 24, 2022
SimSearch: A Human-in-The-Loop Learning Framework for Fast Detection of Regions of Interest in Microscopy ImagesAnkit Gupta, Alan Sabirsh, Carolina Wahlby, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 21, 2005
Non-specific effects of leukotriene synthesis inhibitors on HeLa cell physiologyAlan Sabirsh, Jesper Bristulf, Ulf Karlsson, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 21, 2007
Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils: novel lipid-peptide interactions in innate immune responsesMin Wan, Alan Sabirsh, Anders Wetterholm, et al.
Biochemistry|May 4, 2006
Residues from transmembrane helices 3 and 5 participate in leukotriene B4 binding to BLT1Alan Sabirsh, Robert P Bywater, Jesper Bristulf, et al.
Journal of Lipid Research|February 24, 2006
15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cellsOliver Schröder, Yulyana Yudina, Alan Sabirsh, et al.
Journal of Lipid Research|April 5, 2005
Fluorescent leukotriene B4: potential applicationsAlan Sabirsh, Anders Wetterholm, Jesper Bristulf, et al.
Nature Communications|May 9, 2024
Reply to: Technical challenges of studying the impact of plasma components on the efficacy of lipid nanoparticles for vaccine and therapeutic applicationsKai Liu, Elisa Lázaro-Ibáñez, Michael Lerche, et al.
Chemistryopen|April 8, 2021
A Novel Graphene Quantum Dot-Based mRNA Delivery PlatformYa Liu, Changhong Zhao, Alan Sabirsh, et al.
Pageof 4